|
|
||||||||




*
Laboratory of Host Defense, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Nagoya, Japan;
First Department of Surgery, Gunma University School of Medicine, Maebashi, Japan;
Sections of Infectious Diseases and Immunology, Yale University School of Medicine, New Haven, CT 06520;
Infectious Disease Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Immunology Program, Sloan-Kettering Institue, New York, NY 10021
| Abstract |
|---|
|
|
|---|
in response to
LLO9199, and an adoptive transfer of CD8+ T
cells from IL-15 Tg mice infected with L. monocytogenes
conferred a higher level of resistance against L.
monocytogenes in normal mice. The
CD44+CD8+ T cells from infected IL-15 Tg mice
expressed the higher level of Bcl-2. Transferred
CD44+CD8+ T cells divided more vigorously in
naive IL-15 Tg mice than in non-Tg mice. These results suggest that
IL-15 plays an important role in long-term maintenance of Ag-specific
memory CD8+ T cells following microbial exposure via
promotion of cell survival and homeostatic
proliferation. | Introduction |
|---|
|
|
|---|
IL-15 uses
- and
-chains of IL-2R for signal transduction and
thus shares many properties of IL-2 despite having no sequence homology
with it (15, 16, 17, 18). Similar to IL-2, IL-15 promotes
activation, proliferation, and cytokine release of various subsets of
T, NK, and B cells (19, 20, 21). However, in contrast to IL-2,
which accelerates activation-induced cell death in
CD8+ T cells, IL-15 maintains the homeostasis of
memory phenotype CD8+ T cells (22, 23). We have previously constructed transgenic
(Tg)3 mice expressing
IL-15 cDNA encoding a secretable isoform of the IL-15 precursor protein
under the control of an MHC class I promoter, and we found that the
IL-15 Tg mice, producing IL-15 constitutively, had markedly increased
numbers of memory-type
(CD44highLy6C+)
CD8+ T cells in the periphery lymphoid tissue
(22). IL-15 Tg mice showed resistance against infection
with Salmonella choleraesuis, Listeria
monocytogenes, or Mycobacterium bovis accompanied by
marked increases in memory CD8+ T cells
(22, 24, 25). We have also reported that IL-15 Tg mice
showed increased CD8+ Tc1 cell responses
producing IFN-
following multiple immunization with OVA/CFA
(26). Thus, our IL-15 Tg mice may be useful for
determining molecular mechanisms whereby IL-15 play a role in
generation and/or maintenance of Ag-driven memory
CD8+ T cells.
To this end, we followed the fate of Ag-specific CD8+ T cells directly visualized with MHC class I tetramers coupled with listeriolysin O (LLO)9199 in IL-15 Tg mice after L. monocytogenes infection. We found that the number of LLO9199-specific CD8+ T cells had increased significantly at 3 and 6 wk after infection in IL-15 Tg mice. Both cell survival and homeostatic proliferation of Ag-specific memory CD8+ T cells are suggested to be involved in persistence of Ag-specific memory CD8+ T cells in IL-15 Tg mice.
| Materials and Methods |
|---|
|
|
|---|
IL-15 Tg mice (C57BL/6 background, H-2b, Ly5.2), which were constructed using originally described IL-15 cDNA, have been described previously (22). IL-15 Tg mice with C57BL/6 background were backcrossed onto the BALB/c (H-2d) background more than eight times. Age- and sex-matched BALB/c (H-2d) mice were obtained from Japan SLC (Hamamatsu, Japan). (IL-15 Tg x BALB/c)F1 mice, (C57BL/6 x BALB/c)F1 mice, and B6-Ly5.1 mice (H-2b, Ly5.1) were bred in our laboratory. Mice were maintained under specific pathogen-free conditions and were offered food and water ad libitum. All mice were used at 68 wk of age.
Microorganism
L. monocytogenes, strain EGD, was used in all experiments. Bacterial virulence was maintained by serial passages in BALB/c mice. Fresh isolates were obtained from infected spleens grown in tryptic soy broth (Nissui Pharmaceutical, Tokyo, Japan), washed repeatedly, resuspended in PBS, and stored at -70°C in small aliquots. Mice were inoculated i.p. with various doses of viable L. monocytogenes in 0.2 ml of PBS on day 0. The spleen and liver were removed and separately placed in homogenizers containing 2 ml of HBSS. These samples were spread on trypto-soya agar plates, and colonies were counted after incubation for 24 h at 37°C.
Abs and reagents
FITC-conjugated anti-CD44 (IM7), anti-CD69 (H1.2F3),
anti-Ly6C (AL-21), and anti-IFN-
(XMG1.2); PE-conjugated
anti-CD8
(53-6.7), anti-CD44 (IM7), anti-CD62L (MEL-14),
and anti-CD25 (7D4); CyChrome-conjugated anti-CD8
(53-6.7),
and anti-CD4 (RM4-5); and biotin-conjugated anti-Ly5.1 (A20)
were purchased from BD PharMingen (San Diego, CA). CyChrome and
allophycocyanin-conjugated streptavidin were also obtained from
BD PharMingen. CFSE was purchased from Molecular Probes (Eugene,
OR).
Generation of H2-Kd tetramers
MHC-peptide tetramers for staining of epitope-specific cells
were generated as recently described (27, 28). Briefly,
purified H chain and
2-microgobulin were
dissolved in 8 M urea and diluted in a refolding buffer containing high
concentrations of synthetic peptide LLO9199
(29) or the Janus kinase (JAK)1 self-peptide
(30) to generate monomeric, soluble
H2-Kd-peptide complexes. Biotinylation and
tetramerization of the heterodimer were performed as described by
Altman et al. (27). The monomeric complexes were
tetramerized by the addition of PE-labeled streptavidin (BD PharMingen)
at a molar ratio of 4:1.
Flow cytometry analysis
The cells were incubated with saturating amounts of FITC-, PE-,
CyChrome-, and biotin-conjugated mAbs for 30 min at 4°C. To detect
biotin-conjugated mAbs, cells were stained with CyChrome or
allophycocyanin-conjugated streptavidin. For staining of
epitope-specific CD8+ T cells using tetrameric
H2-Kd-peptide complexes, cells were incubated at
4°C for 20 min in unconjugated streptavidin (0.5 mg/ml;
Sigma-Aldrich, St. Louis, MO) and Fc-block (2.4G2), followed by triple
staining with FITC-CD44, CyChrome-CD8
, and PE-conjugated tetrameric
H2-Kd/peptide complex (0.20.5 mg/ml) for 30 min
at 4°C. The cells were analyzed using an FACSCalibur flow cytometer
(BD Biosciences, San Jose, CA).
Analysis of intracellular cytokine synthesis
The spleen cells from infected mice were harvested, washed, and
suspended at 106 cells/ml in complete culture
medium, and then were incubated for 4 h at 37°C in the presence
of 10 µg/ml brefeldin A (Sigma-Aldrich), 5 µg/ml
LLO9199, or JAK1 peptide. These cells were
harvested, washed, and incubated for 30 min at 4°C with PE-conjugated
anti-CD44 mAb and CyChrome-conjugated CD8 mAb. After surface
staining, cells were subjected to intracellular cytokine staining using
the Fast Immune Cytokine System according to the manufacturers
instructions (BD Biosciences). The cells were washed and fixed in 1000
µl of FACS lysing solution (BD Biosciences) for 10 min at room
temperature and were then washed again, resuspended in 500 µl of FACS
permeabilizing solution (BD Biosciences), and incubated for 10 min at
room temperature. After washing, the cells were stained with
FITC-conjugated IFN-
mAb or FITC-conjugated isotype control rat IgG
(BD PharMingen) for 30 min at room temperature, and the fluorescence of
the cells was analyzed using a flow cytometer.
Before staining for intracellular Bcl-2, cells were stained for cell surface Ags as describe above. After washing, cells were fixed and permeabilized with above solution. Cells were stained with either FITC-conjugated hamster anti-mouse Bcl-2 mAb (3F11) or its isotype FITC-conjugated control Ab to hamster (BD PharMingen).
Adoptive transfer assays
Nylon wool-enriched spleen T cells were incubated with
appropriate dilutions of FITC-conjugated
anti-I-Ad, IgM, and biotinylated
anti-DX-5, -CD11c, and -
TCR mAbs, and were washed twice in
HBSS. The cells were then incubated with anti-FITC microbeads,
streptavidin microbeads, and anti-CD4 mAb microbeads for 15 min at
4°C. CD8+ T cells were enriched to >90% by
negative selection using LD+ depletion columns
(Miltenyi Biotec, Bergisch Gladbach,Germany). Enriched
CD8+ T cells (1 x 107
cells) were adoptively transferred into recipient mice via tail vein
inoculation. At 12 h after adoptive transfer of these cells, mice
were i.p. challenged with a lethal dose of L. monocytogenes
(1 x 106 CFU) and 3 days later the number
of bacteria in the peritoneal cavity, spleen, and liver were counted.
In an another experiment, purified CD8+ T cells
from Ly5.1-B6 mice infected with L. monocytogenes 7 days
previously were suspended at a concentration of 15 x
107/ml in PBS and then labeled with CFSE at a
concentration of 5 mM for 10 min. CFSE-labeled
CD8+ T cells were inoculated i.v. into naive
(IL-15 Tg x BALB/c)F1 mice or naive
(C57BL/6 x BALB/c)F1 mice. After 6 wk,
transferred Ly5.1+ T cells were analyzed using a
flow cytometer.
RT-PCR
LLO9199-specific
CD44+CD8+ T cells were
sorted from IL-15 Tg or non-Tg mice on day 7 or 21 after L.
monocytogenes infection using FACSVantage (BD Biosciences). The
first-strand cDNA synthesized from the mRNA was amplified using 10 pmol
of each primer specific for murine
-actin, CCR7, CXCR3, Bcl-2,
Bcl-XL, or caspase-8/Fas-associated death domain protein-like
IL-1
-converting enzyme inhibitory protein (FLIP). The specific
primers were as follows:
-actin sense,
5'-GGAATCCTGTGGCATCCATGAAAC-3'; antisense,
5'-TAAAACGCAGCTCAGTAACAGTCCG-3'; CCR7 sense,
5'-GAGATGCTCACTGGTCAGTG-3'; antisense,
5'-CTACGGGGAGAAGGTTGTGG-3'; CXCR3 sense, 5'-CAACATCAACTTCTATGCAG-3';
antisense, 5'-AGGATATGGGCATAGCAGTA-3'; Bcl-2 sense,
5'-TGGCCTTCTTTGAGTTCGGT-3'; antisense, 5'-AGCCTCCGTTATCCTGGATC-3';
Bcl-XL sense, 5'-CCGGAGAGCGTTCAGTGATC-3'; antisense,
5'-TCAGGAACCAGCGGTTGAAG-3'; and FLIP sense,
5'-GTCACATGACATAACCCAGATTGT-3'; and antisense,
5'-GTACAGACTGCTCTCCCAAGCACT-3'. The PCR products were separated on 1%
agarose gels, transferred to a GeneScreen Plus filter (NEN, Boston,
MA), and hybridized with 32P-labeled oligo
probes. The oligonucleotide probes were as follows:
-actin,
5'-TTCTGCATCCTGTCAGCAAT-3'; CCR7, 5'-CGCCGATGAAGGCATACAAG-3';
CXCR3, 5'-CTCACCTGCATAGTTGTATG-3'; Bcl-2,
5'-CCGGTTCAGGTACTCAGTCA-3'; Bcl-XL, 5'-CTGCATCTCCTTGTCTACGC-3';
and FLIP, 5'-CTAAGGAATGTAAGTAGGGA-3'.
Statistical analysis
Data were analyzed by Students t test, and a Bonferroni correction was applied for multiple comparison. The value of p < 0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
To directly follow the fate of the L. monocytogenes
epitope-specific CD8+ T cells in IL-15 Tg mice
after an i. p. inoculation with 1 x 105 CFU
of L. monocytogenes, tetrameric MHC molecule folding with
the LLO9199 peptide, the immunodominant epitope
recognized by H2-Kd-restricted
CD8+ T cells (29), was used for
staining epitope-specific CD8+ T cells.
Consistent with our previous finding (24), we found that
the bacterial number increased to a maximal level on day 3 in the
spleen and liver and thereafter cleared completely by day 10 after
inoculation in both non-Tg mice and IL-15 Tg mice and that the bacteria
were more rapidly eliminated in IL-15 Tg mice than in non-Tg mice (data
not shown). As shown in Fig. 1
, a
significant number of CD8+ T cells expressing a
high level of CD44 in non-Tg mice infected with L.
monocytogenes 7 days previously were stained with
H2-Kd/LLO9199 tetramers,
whereas only a few CD8+ T cells in IL-15 Tg mice
were stained with
H2-Kd/LLO9199 tetramers
on day 7 after infection. The absolute numbers of
H2-Kd/LLO9199
peptide-positive CD8+ T cells in the splenocytes
were 2.8 ± 0.4 x 105 cells in non-Tg
mice and 2.3 ± 0.9 x 105 cells in
IL-15 Tg mice (Fig. 2
). Thus, the number
of LLO9199-specific T cells in the spleen of
IL-15 Tg mice was similar to that in the spleen of non-Tg mice at the
early stage after infection because memory
CD44+CD8+ T cells other
than those specific for LLO9199 were markedly
increased in IL-15 Tg mice at this stage.
|
|
Listeria-specific memory CD8+ T cells in IL-15 Tg mice function to protect against L. monocytogenes infection
Besides Th1 response, Tc1 response also plays a critical role in
protective immunity against L. monocytogenes infection
(31). To determine whether the memory
CD8+ T cells in IL-15 Tg mice belong to the Tc1
cell population, we used cytokine FACS analysis for expression of CD8,
CD44, and intracellular IFN-
. As shown in Fig. 3
, a significant fraction of
CD44+CD8+ T cells from both
groups of mice infected with L. monocytogenes 21 days
previously produced IFN-
in response to
LLO9199, and the level of
CD8+ Tc1 cells producing IFN-
was
significantly higher in IL-15 Tg mice than in non-Tg mice at this
stage. It is notable that the relative number of intracellular
IFN-
-positive CD8+ T cells responding to
LLO9199 in vitro was consistent with that of
CD8+ T cells directly stained with
H2-Kd/LLO9199 tetramers
in non-Tg or IL-15 Tg mice, respectively (Figs. 1
and 3
).
|
|
Antiapoptotic molecules play a critical role in regulating cell
survival and apoptosis of memory T cells (32). We next
sorted LLO9199-specific
CD44+CD8+ T cells from
non-Tg and IL-15 Tg mice on day 7 or 21 after infection and compared
the gene expressions of CCR7, CXCR3, and antiapoptotic molecules such
as Bcl-2, Bcl-XL, or FLIP. CCR7, which is expressed specifically in
central memory T cells (33), was not expressed in
LLO9199-specific
CD44+CD8+ T cells on day 7
after L. monocytogenes infection, but its expression was
up-regulated in those cells on day 21 after L. monocytogenes
infection (Fig. 5
). These results are
consistent with surface markers for effector and memory on
LLO9199-specific
CD44+CD8+ T cells on day 7
or 21, respectively. CXCR3, which is expressed by Th1/Tc1 cells
(34), was expressed by both
LLO9199-specific
CD44+CD8+ T cells on days 7
and 21, a finding that is also consistent with
CD44+CD8+ Tc1 cells capable
of IFN-
production upon LLO9199 stimulation.
Notably, LLO9199-specific
CD44+CD8+ T cells in IL-15
Tg mice on day 7 after infection showed a higher level of Bcl-2 gene
expression than those in non-Tg mice did. There were no remarkable
differences in gene expression of Bcl-XL and that of FLIP, an inhibitor
of the Fas/Fas ligand signaling pathway (35).
|
|
The number of memory T cells is maintained by a balance
among cell survival, apoptosis, and proliferation
(1, 2, 3, 4). To elucidate whether cell division is involved in
increases in Ag-driven memory CD8+ T cells in
IL-15 Tg mice, we performed a transfer experiment with CFSE-labeled
CD8+ T cells from the spleen of non-Tg mice
infected with L. monocytogenes 7 days previously into naive
non-Tg or IL-15 Tg mice, and we analyzed cell division in vivo 6 wk
later. As shown in Fig. 7
and Table I
, more
CD44+CD8+ T cells entered
the cell cycle in IL-15 Tg mice than in non-Tg mice 6 wk after
injection. These results suggest that memory CD8+
T cells persist by cell division in IL-15 Tg mice.
|
|
| Discussion |
|---|
|
|
|---|
A key issue is the molecular mechanisms whereby IL-15 regulates the
size of Ag-driven memory CD8+ T cells in the
periphery following a microbial infection. It can be speculated that
overexpression of IL-15 in vivo may enhance the generation of effector
CD8+ T cells after L. monocytogenes
infection, resulting in an increase in the number of memory
CD8+ T cells. However, the results of our
previous (24) and present studies revealed that the
absolute number of LLO9199-specific effector
CD8+ T cells in IL-15 Tg mice was similar or
rather smaller than that in non-Tg mice on day 7 after infection,
excluding the above-mentioned possibility. The
LLO9199-specific CD8+ T
cells from IL-15 Tg mice infected with L. monocytogenes 7
days previously expressed CD69 but not CCR7 mRNA, indicating that these
cells are effector cells. The CD8+ effector T
cells expressed a higher level of Bcl-2 genes than did those in non-Tg
mice. Bcl-2 expression is induced via signaling from the common
cytokine receptor
-chain (36), which is used by IL-15
(37) and prevents apoptosis by both activation-induced
cell death and withdrawal of growth factors (1). In fact,
annexin V expression in
CD44+CD8+ T cells of IL-15
Tg mice was significantly lower on day 7 after L.
monocytogenes infection than that seen in non-Tg mice (data not
shown). Therefore, it is likely that overexpression of IL-15 protects
the effector CD8+ T cells from apoptosis by
activation-induced cell death and/or withdrawal of growth factors,
resulting in an increased number of memory CD8+ T
cells. We have recently reported that IL-15 Tg mice showed augmented
Tc1 responses against bacillus Calmette-Guérin infection
(25) and against multiple immunization with OVA in CFA
(26). Augmented Tc1 responses in these reports may be
explained by increases in the memory CD8+ T cells
following OVA or bacillus Calmette-Guérin immunization.
Cell division is thought to be required for the long-term maintenance of Ag-driven memory CD8+ T cells in vivo (38, 39). The results of our transfer experiments suggest that the transferred CD44+CD8+ T cells divided more at 6 wk in naive IL-15 Tg mice than in naive non-Tg mice. These results suggest that memory CD8+ T cells have a higher rate of homeostatic proliferation in IL-15 Tg mice than in non-Tg mice. IL-15 may play a role in the long-term survival of memory T cells in vivo by cell division of memory CD8+ T cells in addition to protection from activation-induced apoptosis. Recent studies have provided several lines of evidence for homeostatic proliferation of naive CD8+ T cells (5, 6, 7, 8, 9). Naive CD8+ T cells can acquire characteristics of memory T cells in the absence of stimulation with a specific Ag, but by stimulation with self-MHC class I/peptide ligand (6, 7). Therefore, memory CD8+ T cells include not only true Ag-experienced cells but also memory cells derived from naive cells via homeostatic proliferation. Additional experiments are needed to elucidate the roles of IL-15 in the homeostasis of memory CD8+ T cells directly derived from naive CD8+ T cells.
IL-15 mRNA is constitutively expressed by various cells and tissues such as placenta, skeletal muscle, kidney, epithelial cells, synovial cells, and macrophages (21, 40). IL-15 expression is regulated not only at the transcriptional level but also at levels of translation and intracellular trafficking (41, 42, 43, 44, 45, 46). Hence, IL-15 protein was found to be produced only by a limited number of cells such as LPS-stimulated macrophages and bacteria-stimulated epithelial cells, but not by other cells including T cells (41, 47). Masopust et al. (48) have recently reported that Ag-specific memory T cells are maintained preferentially in nonlymphoid tissues such as lamina propria of intestine for the long term. Because IL-15 is thought to be produced abundantly in intestinal epithelium, IL-15 may play a critical role in the long-term maintenance of Ag-driven memory CD8+ T cell in the nonlymphoid tissues.
In conclusion, overexpression of IL-15 in vivo shed light on the role of IL-15 in long-term maintenance of memory CD8+ T cells in vivo. IL-15 may promote linear differentiation of effector CD8+ T cells into memory CD8+ T cells through protection from activation-induced cell death by apoptosis and may maintain memory CD8+ T cells through induction of cell division. These findings suggest that IL-15 may be useful as an immune adjuvant given with vaccination to enhance its biologic efficacy.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Yasunobu Yoshikai, Laboratory of Host Defense, Research Institute for Disease Mechanism and Control, Nagoya University School of Medicine, Nagoya 466-8550, Japan. E-mail address; yyoshika{at}med.nagoya-u.ac.jp ![]()
3 Abbreviations used in this paper: Tg, transgenic; LLO, listeriolysin O; FLIP, caspase-8/Fas-associated death domain protein-like IL-1
-converting enzyme inhibitory protein; JAK, Janus kinase. ![]()
Received for publication September 26, 2001. Accepted for publication November 29, 2001.
| References |
|---|
|
|
|---|

TCR+ T cells. Nat. Immunol. 1:107.[Medline]
-chain of the interleukin-2 receptor. Science 246:965.
- and
-chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 8:3667.[Medline]
-chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940.This article has been cited by other articles:
![]() |
S. C. Morris, S. M. Heidorn, D. R. Herbert, C. Perkins, D. A. Hildeman, M. V. Khodoun, and F. D. Finkelman Endogenously Produced IL-4 Nonredundantly Stimulates CD8+ T Cell Proliferation J. Immunol., February 1, 2009; 182(3): 1429 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gill and A. A. Ashkar Overexpression of Interleukin-15 Compromises CD4-Dependent Adaptive Immune Responses against Herpes Simplex Virus 2 J. Virol., January 15, 2009; 83(2): 918 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Rubinstein, N. A. Lind, J. F. Purton, P. Filippou, J. A. Best, P. A. McGhee, C. D. Surh, and A. W. Goldrath IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response Blood, November 1, 2008; 112(9): 3704 - 3712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Kokaji, D. L. Hockley, and K. P. Kane IL-15 Transpresentation Augments CD8+ T Cell Activation and Is Required for Optimal Recall Responses by Central Memory CD8+ T Cells J. Immunol., April 1, 2008; 180(7): 4391 - 4401. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, H. Yamada, T. Yajima, R. Nakagawa, K. Shimoda, K. Nakayama, and Y. Yoshikai Tyk2 Signaling in Host Environment Plays an Important Role in Contraction of Antigen-Specific CD8+ T Cells following a Microbial Infection J. Immunol., April 1, 2007; 178(7): 4482 - 4488. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakazato, H. Yamada, T. Yajima, Y. Kagimoto, H. Kuwano, and Y. Yoshikai Enforced Expression of Bcl-2 Partially Restores Cell Numbers but Not Functions of TCR{gamma}{delta} Intestinal Intraepithelial T Lymphocytes in IL-15-Deficient Mice J. Immunol., January 15, 2007; 178(2): 757 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lucas, S.-J. Kim, C. L. Mackall, W. G. Telford, Y.-W. Chu, F. T. Hakim, and R. E. Gress Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice Blood, October 15, 2006; 108(8): 2789 - 2795. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saito, T. Yajima, S. Kumabe, T. Doi, H. Yamada, S. Sad, H. Shen, and Y. Yoshikai Impaired Protection against Mycobacterium bovis Bacillus Calmette-Guerin Infection in IL-15-Deficient Mice J. Immunol., February 15, 2006; 176(4): 2496 - 2504. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yajima, K. Yoshihara, K. Nakazato, S. Kumabe, S. Koyasu, S. Sad, H. Shen, H. Kuwano, and Y. Yoshikai IL-15 Regulates CD8+ T Cell Contraction during Primary Infection J. Immunol., January 1, 2006; 176(1): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishimura, T. Yajima, H. Muta, E. R. Podack, K. Tani, and Y. Yoshikai A Novel Role of CD30/CD30 Ligand Signaling in the Generation of Long-Lived Memory CD8+ T Cells J. Immunol., October 1, 2005; 175(7): 4627 - 4634. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. N. Toka and B. T. Rouse Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity J. Leukoc. Biol., July 1, 2005; 78(1): 178 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lazarevic, D. J. Yankura, S. J. Divito, and J. L. Flynn Induction of Mycobacterium tuberculosis-Specific Primary and Secondary T-Cell Responses in Interleukin-15-Deficient Mice Infect. Immun., May 1, 2005; 73(5): 2910 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yajima, H. Nishimura, S. Sad, H. Shen, H. Kuwano, and Y. Yoshikai A Novel Role of IL-15 in Early Activation of Memory CD8+ CTL after Reinfection J. Immunol., March 15, 2005; 174(6): 3590 - 3597. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Blaser, S. Roychowdhury, D. J. Kim, N. R. Schwind, D. Bhatt, W. Yuan, D. F. Kusewitt, A. K. Ferketich, M. A. Caligiuri, and M. Guimond Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease Blood, January 15, 2005; 105(2): 894 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gilbertson, S. Germano, P. Steele, S. Turner, B. F. de St. Groth, and C. Cheers Bystander Activation of CD8+ T Lymphocytes during Experimental Mycobacterial Infection Infect. Immun., December 1, 2004; 72(12): 6884 - 6891. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yajima, H. Nishimura, K. Saito, H. Kuwano, and Y. Yoshikai Overexpression of Interleukin-15 Increases Susceptibility to Lipopolysaccharide-Induced Liver Injury in Mice Primed with Mycobacterium bovis Bacillus Calmette-Guerin Infect. Immun., July 1, 2004; 72(7): 3855 - 3862. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Johnson Murine Oviduct Epithelial Cell Cytokine Responses to Chlamydia muridarum Infection Include Interleukin-12-p70 Secretion Infect. Immun., July 1, 2004; 72(7): 3951 - 3960. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Lenz, S. K. Kurz, E. Lemmens, S. P. Schoenberger, J. Sprent, M. B. A. Oldstone, and D. Homann IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory PNAS, June 22, 2004; 101(25): 9357 - 9362. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Lawrence and B. A. Vorderstrasse Activation of the Aryl Hydrocarbon Receptor Diminishes the Memory Response to Homotypic Influenza Virus Infection but Does Not Impair Host Resistance Toxicol. Sci., June 1, 2004; 79(2): 304 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Huster, V. Busch, M. Schiemann, K. Linkemann, K. M. Kerksiek, H. Wagner, and D. H. Busch Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets PNAS, April 13, 2004; 101(15): 5610 - 5615. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Giri, K. E. Ugen, and D. B. Weiner DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade Clin. Microbiol. Rev., April 1, 2004; 17(2): 370 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rothenfusser, V. Hornung, M. Ayyoub, S. Britsch, A. Towarowski, A. Krug, A. Sarris, N. Lubenow, D. Speiser, S. Endres, et al. CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro Blood, March 15, 2004; 103(6): 2162 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chapdelaine, D. K. Smith, J. A. Pedras-Vasconcelos, L. Krishnan, and S. Sad Increased CD8+ T Cell Memory to Concurrent Infection at the Expense of Increased Erosion of Pre-existing Memory: The Paradoxical Role of IL-15 J. Immunol., November 15, 2003; 171(10): 5454 - 5460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Umemura, H. Nishimura, K. Saito, T. Yajima, G. Matsuzaki, S. Mizuno, I. Sugawara, and Y. Yoshikai Interleukin-15 as an Immune Adjuvant To Increase the Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin Vaccination Infect. Immun., October 1, 2003; 71(10): 6045 - 6048. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tritel, A. M. Stoddard, B. J. Flynn, P. A. Darrah, C.-y. Wu, U. Wille, J. A. Shah, Y. Huang, L. Xu, M. R. Betts, et al. Prime-Boost Vaccination with HIV-1 Gag Protein and Cytosine Phosphate Guanosine Oligodeoxynucleotide, Followed by Adenovirus, Induces Sustained and Robust Humoral and Cellular Immune Responses J. Immunol., September 1, 2003; 171(5): 2538 - 2547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Berard, K. Brandt, S. B. Paus, and D. F. Tough IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells J. Immunol., May 15, 2003; 170(10): 5018 - 5026. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oh, J. A. Berzofsky, D. S. Burke, T. A. Waldmann, and L. P. Perera Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity PNAS, March 18, 2003; 100(6): 3392 - 3397. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Mueller, P. M. Bojczuk, E. S. Halstead, A. H. J. Kim, J. Witek, J. D. Altman, and P. D. Katsikis IL-15 enhances survival and function of HIV-specific CD8+ T cells Blood, February 1, 2003; 101(3): 1024 - 1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Meunier, G. Roy-Proulx, N. Labrecque, and C. Perreault Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy Blood, January 15, 2003; 101(2): 766 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Mueller, V. Makar, P. M. Bojczuk, J. Witek, and P. D. Katsikis IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells Int. Immunol., January 1, 2003; 15(1): 49 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Rubinstein, A. N. Kadima, M. L. Salem, C. L. Nguyen, W. E. Gillanders, and D. J. Cole Systemic Administration of IL-15 Augments the Antigen-Specific Primary CD8+ T Cell Response Following Vaccination with Peptide-Pulsed Dendritic Cells J. Immunol., November 1, 2002; 169(9): 4928 - 4935. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Prlic, L. Lefrancois, and S. C. Jameson Multiple Choices: Regulation of Memory CD8 T Cell Generation and Homeostasis by Interleukin (IL)-7 and IL-15 J. Exp. Med., June 17, 2002; 195(12): F49 - F52. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |